News Releases Sona Nanotech’s THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-reviewed Scientific Journal
News Releases Sona Nanotech’s THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study
Webinars Join Sona Nanotech’s CEO, David Regan, and CMO, Dr. Carman Giacomantonio, December 11th 2024
News Releases Sona Nanotech to Showcase its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update
News Releases Sona Nanotech Closes Private Placement Financing to Raise $1,500,000 in Gross Proceeds and Announces Additional Financing
News Releases Sona’s Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study
Media & Interviews Revolutionary Cancer Therapy: Sona Nanotech’s Gold Nanorods Shrink Tumors from the Inside Out
News Releases Sona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and Development